SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-044083
Filing Date
2021-06-30
Accepted
2021-06-30 18:47:19
Documents
1
Period of Report
2021-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3965
  Complete submission text file 0001209191-21-044083.txt   5325
Mailing Address 101 POOR FARM ROAD 3RD FLOOR PRINCETON NJ 08540
Business Address
Garner Elizabeth (Reporting) CIK: 0001608578 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38542 | Film No.: 211063296

Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Issuer) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations